Le Lézard
Classified in: Science and technology, Business
Subject: CXP

DataBank Completes FedRAMP Authorization for its Dallas and Minnesota Data Centers


DALLAS, Nov. 19, 2019 /PRNewswire/ -- DataBank, a leading provider of enterprise-class data center, connectivity and managed services, announces today the completion of its reassessments and maintenance of existing authorizations of the General Services Administration's (GSA) Federal Risk and Authorization Management Program (FedRAMP). FedRAMP provides a standardized approach to security and risk assessment, authorization and continuous monitoring, essential for organizations in this digital age. In addition, DataBank added two new data center facilities to its FedRAMP portfolio, DFW3 in Dallas, Texas and MSP2 in Minneapolis, Minnesota. DataBank's Baltimore data center also meets the FedRAMP designation.

DataBank logo (PRNewsfoto/DataBank)

"The FedRAMP certification of DFW3 and MSP2 are part of DataBank's plans to more than double its FedRAMP compliant Infrastructure as a service (IaaS) capacity, a capability that is important for our customers in achieving high-security environments," states Mark Houpt, Chief Information Security Officer for DataBank. "As a direct response to serving our customers' needs on multiple levels, the certifications for DFW3 and MSP2 mark our commitment to compliance enablement, operational excellence and maintaining a secure facility."

DataBank DFW3 and MSP2 facilities are Uptime Certified Tier III constructed data centers and are marked by multiple layers of physical security and hardened infrastructure including:

For more information, visit www.databank.com.

About DataBank
DataBank is a leading provider of enterprise-class data center, cloud, and connectivity services, offering customers 100% uptime availability of data, applications, and infrastructure. DataBank's managed data center services are anchored in world-class facilities. Our customized technology solutions are designed to help customers effectively manage risk, improve their technology performance, and allow them to focus on their core business objectives. DataBank is headquartered in the historic former Federal Reserve Bank Building, in downtown Dallas, TX. For additional information on DataBank locations and services, please visit www.databank.com or call 1 (800) 840-7533.

 

SOURCE DataBank


These press releases may also interest you

at 13:05
Cortexyme, Inc. today announced the presentation of new data supporting the on-target activity of COR388, its lead investigational medicine, and linking the "gingipain hypothesis" for Alzheimer's disease (AD) to the significance of the APOE gene as...

at 12:05
Stoke Therapeutics, Inc. , a biotechnology company pioneering a new way to treat the underlying cause of severe genetic diseases by precisely upregulating protein expression, today announced preclinical data from studies of STK-001 that showed...

at 11:05
Aptose Biosciences Inc. released highlights from a corporate event and clinical update today held at the 61st American Society of Hematology (ASH) Annual Meeting and Exposition in Orlando, FL. The event was hosted by the Aptose management team and...

at 11:00
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Resideo Technologies, Inc. between October 10, 2018 and October 22, 2019, inclusive (the "Class Period") of the important January 7, 2020 lead plaintiff...

at 10:25
The Janssen Pharmaceutical Companies of Johnson & Johnson announced today initial results from the Phase 1b/2 CARTITUDE-1 study (NCT03548207) evaluating the efficacy and safety of JNJ-68284528 (JNJ-4528), an investigational B cell maturation antigen...

at 10:20
The Janssen Pharmaceutical Companies of Johnson & Johnson today announced combination data from two studies and a long-term integrated analysis evaluating the use of Imbruvica® (ibrutinib) for the treatment of previously untreated patients with CLL....



News published on 19 november 2019 at 08:01 and distributed by: